These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29398467)

  • 21. Ductal carcinoma in situ: through a glass, darkly.
    Lagios MD; Silverstein MJ
    Ann Surg Oncol; 2008 Jan; 15(1):16-7. PubMed ID: 18043977
    [No Abstract]   [Full Text] [Related]  

  • 22. Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S. Payer Perspective.
    Mistry R; May JR; Suri G; Young K; Brixner D; Oderda G; Biskupiak J; Tang D; Bhattacharyya S; Mishra D; Bhattacharyya D; Dalal AA
    J Manag Care Spec Pharm; 2018 Jun; 24(6):514-523. PubMed ID: 29799329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palbociclib: first global approval.
    Dhillon S
    Drugs; 2015 Apr; 75(5):543-51. PubMed ID: 25792301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.
    Vidali C; Caffo O; Aristei C; Bertoni F; Bonetta A; Guenzi M; Iotti C; Leonardi MC; Mussari S; Neri S; Pietta N
    Radiat Oncol; 2012 Oct; 7():177. PubMed ID: 23098066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of care with regard to surgical choice and application of adjuvant radiation therapy for preinvasive and early stage breast cancer in rural Appalachia.
    Freeman AB; Huang B; Dragun AE
    Am J Clin Oncol; 2012 Aug; 35(4):358-63. PubMed ID: 21422902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraductal carcinoma of the breast. (1960-1969).
    Ashikari R; Hajdu SI; Robbins GF
    Cancer; 1971 Nov; 28(5):1182-7. PubMed ID: 4331139
    [No Abstract]   [Full Text] [Related]  

  • 27. CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment.
    DeMichele A; Clark AS; Tan KS; Heitjan DF; Gramlich K; Gallagher M; Lal P; Feldman M; Zhang P; Colameco C; Lewis D; Langer M; Goodman N; Domchek S; Gogineni K; Rosen M; Fox K; O'Dwyer P
    Clin Cancer Res; 2015 Mar; 21(5):995-1001. PubMed ID: 25501126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
    Jackson LC; Camacho F; Levine EA; Anderson RT; Stewart JH
    Am J Surg; 2008 Feb; 195(2):164-9. PubMed ID: 18096124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A practice guideline for diagnosis and treatment of ductal in situ carcinoma of the breast].
    Delaloye JF; Wight E; Fink D; Otto R; Steiner R;
    Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):64-7. PubMed ID: 16452823
    [No Abstract]   [Full Text] [Related]  

  • 30. NCCN: Breast cancer.
    Carlson RW; Edge SB; Theriault RL;
    Cancer Control; 2001; 8(6 Suppl 2):54-61. PubMed ID: 11760559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Palbociclib (PD0332991)-a Selective and Potent Cyclin-Dependent Kinase Inhibitor: A Review of Pharmacodynamics and Clinical Development.
    Clark AS; Karasic TB; DeMichele A; Vaughn DJ; O'Hara M; Perini R; Zhang P; Lal P; Feldman M; Gallagher M; O'Dwyer PJ
    JAMA Oncol; 2016 Feb; 2(2):253-60. PubMed ID: 26633733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Outcomes of Multiple-Wire Localizations for More Extensive Breast Cancer: Multiple-Wire Excision Does Not Increase Recurrence, Unplanned Imaging, or Biopsies.
    Brown CL; McEvoy MP; Smith BL; Lanahan CR; Kelly BN; Coopey SB; Hughes KS; Oseni TS; McGugin C; Wong SM; Gadd MA; Specht MC
    Clin Breast Cancer; 2020 Jun; 20(3):215-219. PubMed ID: 31859233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: Trends in the treatment of ductal carcinoma in situ of the breast.
    Zorbas H; Luxford K; Evans A; Villanueva EV
    J Natl Cancer Inst; 2004 Aug; 96(16):1258; author reply 1259-60. PubMed ID: 15316063
    [No Abstract]   [Full Text] [Related]  

  • 34. Ectopic breast cancer: special treatment considerations in the postmenopausal patient.
    Roorda AK; Hansen JP; Rider JA; Huang S; Rider DL
    Breast J; 2002; 8(5):286-9. PubMed ID: 12199756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent use of palbociclib and radiation therapy: single-centre experience and review of the literature.
    Beddok A; Xu HP; Henry AA; Porte B; Fourquet A; Cottu P; Kirova Y
    Br J Cancer; 2020 Sep; 123(6):905-908. PubMed ID: 32595213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ductal carcinoma in situ--management update.
    Stuart K; Boyages J; Brennan M; Ung O
    Aust Fam Physician; 2005 Nov; 34(11):949-54. PubMed ID: 16299630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Breast cancer treatment].
    Duodecim; 2005; 121(3):317-8. PubMed ID: 15787290
    [No Abstract]   [Full Text] [Related]  

  • 38. Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer.
    Anampa J; Haque T; Murakhovskaya I; Wang Y; Bachiashvili K; Papazoglu C; Pradhan K; Steidl UG; Sparano JA; Verma A
    Haematologica; 2018 Mar; 103(3):e98-e102. PubMed ID: 29191840
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclin-dependent kinase 4/6 inhibitors for the management of advanced or metastatic breast cancer in women.
    Cersosimo RJ
    Am J Health Syst Pharm; 2019 Aug; 76(16):1183-1202. PubMed ID: 31369120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should Everyone With Ductal Carcinoma in Situ Receive Adjuvant Radiation?
    Warren LEG; Bellon JR
    J Clin Oncol; 2021 Nov; 39(32):3535-3540. PubMed ID: 34613792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.